Adlai Nortye (ANL) Short Interest Ratio & Short Volume → Write this ticker symbol down… (From StocksToTrade) (Ad) Free ANL Stock Alerts $10.09 -0.41 (-3.90%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Adlai Nortye Short Interest DataCurrent Short Interest12,000 sharesPrevious Short Interest11,500 sharesChange Vs. Previous Month+4.35%Dollar Volume Sold Short$167,040.00Short Interest Ratio1.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares36,900,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume18,760 sharesAverage Trading Volume6,792 sharesToday's Volume Vs. Average276% Short Selling Adlai Nortye ? Sign up to receive the latest short interest report for Adlai Nortye and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANL Short Interest Over TimeANL Days to Cover Over TimeANL Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Adlai Nortye Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202412,000 shares $167,040.00 +4.4%N/A1.5 $13.92 4/30/202411,500 shares $158,700.00 +101.8%N/A1.6 $13.80 4/15/20245,700 shares $62,415.00 -5.0%N/A0.9 $10.95 3/31/20246,000 shares $53,272.80 +42.9%N/A1.2 $8.88 3/15/20244,200 shares $37,800.00 +55.6%N/A3.5 $9.00 2/29/20242,700 shares $19,305.00 -22.9%N/A1.9 $7.15 2/15/20243,500 shares $25,865.00 +6.1%N/A2.5 $7.39 1/31/20243,300 shares $30,128.67 No ChangeN/A1.7 $9.13 ANL Short Interest - Frequently Asked Questions What is Adlai Nortye's current short interest? Short interest is the volume of Adlai Nortye shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 12,000 shares of ANL short. Learn More on Adlai Nortye's current short interest. What is a good short interest ratio for Adlai Nortye? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANL shares currently have a short interest ratio of 2.0. Learn More on Adlai Nortye's short interest ratio. Is Adlai Nortye's short interest increasing or decreasing? Adlai Nortye saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 12,000 shares, an increase of 4.3% from the previous total of 11,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Adlai Nortye's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Adlai Nortye: PepGen Inc. (1.61%), Applied Therapeutics, Inc. (4.00%), Fulcrum Therapeutics, Inc. (4.97%), Larimar Therapeutics, Inc. (6.13%), Erasca, Inc. (6.60%), Verve Therapeutics, Inc. (29.40%), Corbus Pharmaceuticals Holdings, Inc. (4.86%), Korro Bio, Inc. (2.81%), Travere Therapeutics, Inc. (17.65%), Oculis Holding AG (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Adlai Nortye stock? Short selling ANL is an investing strategy that aims to generate trading profit from Adlai Nortye as its price is falling. ANL shares are trading down $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adlai Nortye? A short squeeze for Adlai Nortye occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANL, which in turn drives the price of the stock up even further. How often is Adlai Nortye's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANL, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PepGen Short Interest Applied Therapeutics Short Interest Fulcrum Therapeutics Short Interest Larimar Therapeutics Short Interest Erasca Short Interest Verve Therapeutics Short Interest Corbus Pharmaceuticals Short Interest Korro Bio Short Interest Travere Therapeutics Short Interest Oculis Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANL) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.